UNSPSC 51393317: Visnafylline

This classification denotes a bronchodilator with the molecular formula C18H22NO5.C7H7N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GB901PL1KW, chemically known as (2-((9-methoxy-7-methyl-5-oxo-5h-furo(3,2-g)(1)benzopyran-4-yl)oxy)ethyl)trimethylammonium theophylline derivate but generally known as visnafylline, which bears US NIH Compound Identifier 3084273. European Medicines Agency schedules Visnafylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00084MIG.

UNSPSC 51393317 Visnafylline, a Commodity code, addresses pharmaceutical products state and local governments procure for public health and emergency response initiatives. However, the recent state and local opportunity tagged to this code — Seminole County, Florida's IFB for naloxone and drug deactivation systems — does not align with the code's nominal scope. Naloxone and drug deactivation equipment fall outside the pharmaceutical active-ingredient taxonomy that visnafylline represents, signaling either a misclassification by the issuing body or a lack of relevant recent procurement activity under this code's intended scope.

Seminole County Community Health Building posted the sole recent opportunity on June 30, 2026 (IFB 60459723LAS, due July 26, 2023), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries. The procurement is potentially FEMA-funded, requires E-Verify compliance and drug-free workplace certification, carries a two-year initial term with one-year renewal option, and imposes a three-month probationary termination clause. Vendors must include all shipping and delivery costs in their bids and maintain workers' compensation, commercial general liability, and professional liability insurance. The code shows limited actionable recent activity aligned with its pharmaceutical classification.